Dyne Therapeutics, Inc.
corporate_fare Company Profile
Dyne Therapeutics, Inc. (NASDAQ:DYN) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 44 items for DYN at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Dyne Therapeutics' Z-Rostudirsen Shows New Positive 24-Month Cardiopulmonary Data in DMD Trial
- Dyne Therapeutics Reports Positive Clinical Data, Outlines BLA & Launch Timelines for DMD & DM1 Programs
- Dyne Therapeutics Details Strong Pipeline Progress and Financial Runway in Annual Report
- Dyne Therapeutics Reports $1.1B Cash, Extending Runway to Q1 2028; Highlights Positive Clinical Data
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$446.21M
Diluted EPS
-$3.47
Op. Cash Flow
-$403.21M
Free Cash Flow
-$405.13M
Operating Income
-$468.18M
Cash & Equivalents
$893.37M
Total Debt
$148.92M
Debt / Equity
0.15×
Shares Outstanding
164.95M sh
Source: 10-K · filed 2026-03-02 · accession 0001193125-26-084178
show_chartPrice Chart
Loading chart...
feed DYN - Filings & News (Page 3)
DYN
Mar 08, 2026, 6:00 PM EDT
Price at Filing:
$15.17
Real-time Price:
$15.50
Change:
+$0.330 (+2%)
Market Cap:
$2.904B
DYN
Mar 02, 2026, 7:35 AM EST
Price at Filing:
$14.96
Real-time Price:
$15.50
Change:
+$0.540 (+4%)
Market Cap:
$2.904B
DYN
Mar 02, 2026, 7:20 AM EST
Price at Filing:
$14.96
Real-time Price:
$15.50
Change:
+$0.540 (+4%)
Market Cap:
$2.904B
DYN
Jan 12, 2026, 7:35 AM EST
Dyne Therapeutics Reports $1.1B Cash, Extending Runway to Q1 2028; Highlights Positive Clinical Data
Price at Filing:
$17.92
Real-time Price:
$15.50
Change:
-$2.42 (-13%)
Market Cap:
$2.904B